Related Experiment Video

Updated: Jan 18, 2026

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

1.5K

Treatment of Necrobiotic Xanthogranuloma With Upadacitinib: A Case Report

Austinn C Miller1,2, Tanner Harding1,2, Jessica Houpe1,2

  • 1Dermatology Associates of Tallahassee, Tallahassee, Florida, USA.

International Journal of Dermatology
|May 30, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
JAK inhibitorJanus kinase inhibitorUpadacitinibnecrobiotic xanthogranuloma (NXG)

More Related Videos

Indocyanine Green-Guided Intraoperative Imaging to Facilitate Video-Assisted Retroperitoneal Debridement for Treating Acute Necrotizing Pancreatitis
04:01

Indocyanine Green-Guided Intraoperative Imaging to Facilitate Video-Assisted Retroperitoneal Debridement for Treating Acute Necrotizing Pancreatitis

Published on: September 8, 2022

2.9K

Related Experiment Videos

Last Updated: Jan 18, 2026

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

1.5K
Indocyanine Green-Guided Intraoperative Imaging to Facilitate Video-Assisted Retroperitoneal Debridement for Treating Acute Necrotizing Pancreatitis
04:01

Indocyanine Green-Guided Intraoperative Imaging to Facilitate Video-Assisted Retroperitoneal Debridement for Treating Acute Necrotizing Pancreatitis

Published on: September 8, 2022

2.9K

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

495
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
495
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

439
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
439

Articles linked to this work by shared authors, journal, and citation graph.

Lack of Rb and p53 Expression in a Case of CM2B4 Negative Merkel Cell Carcinoma In Situ Associated With Squamous Dysplasia.

Journal of cutaneous pathology·2026

Asystole and Laryngospasm After Vagal Nerve Stimulator Generator Replacement: A Case Report.

A&A practice·2025

Comparison of Revision Rates Among Patients Undergoing 2-Level ACDF, CDR, and Hybrid Constructs.

Clinical spine surgery·2025

Spinal implant wear particles: Generation, characterization, biological impacts, and future considerations.

iScience·2025

Advancements and Challenges in Computer-Assisted Navigation for Cervical Spine Surgery: A Comprehensive Review of Perioperative Integration, Complications, and Emerging Technologies.

Global spine journal·2025

Efficient identification of de novo mutations in family trios: a consensus-based informatic approach.

Life science alliance·2025

Implementation of Total Body Photography for Skin Cancer Early Detection: A Systematic Review.

International journal of dermatology·2026

AI Dermatology's Unfulfilled Promise: Why Early Melanoma Detection Remains Unverified.

International journal of dermatology·2026

Mole or Early Melanoma? Rethinking Early Detection, Overdiagnosis, and the Benign-Malignant Paradigm.

International journal of dermatology·2026

Can We Diagnose Early Melanoma by Genomics?

International journal of dermatology·2026

Can We Diagnose Early Melanoma With New Imaging Technologies?

International journal of dermatology·2026

Melanoma Prognostication Using AI-Guided Histopathology.

International journal of dermatology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us